Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis.

CS Kow, SS Hasan - Journal of medical virology, 2021 - search.ebscohost.com
The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is currently the biggest threat to the public health …
被引用次数：83 相关文章

[引用][C] Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis.

CS Kow, SS Hasan - Journal of Medical Virology, 2020 - europepmc.org
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A
meta-analysis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[引用][C] Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis

CS Kow, SS Hasan - Journal of Medical Virology, 2021 - Wiley Online Library
To the Editor, The novel coronavirus disease 2019 (COVID‐19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is currently the biggest threat to the …

Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis

CS Kow, SS Hasan - Journal of Medical Virology, 2021 - pure.hud.ac.uk
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a
meta-analysis — University of Huddersfield Research Portal Skip to main navigation Skip to …

[引用][C] Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis

CS Kow, SS Hasan - Journal of medical virology, 2021 - pubmed.ncbi.nlm.nih.gov
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A
meta-analysis Mortality risk with preadmission metformin use in patients with COVID-19 and …